ALTI vs VRTX · rev $131.1M vs P/E 30, rev $3.33B
Alvarium Tiedemann Holdings Inc. (ALTI) versus Vertex Pharmaceuticals Inc (VRTX) — a side-by-side from cached financials, not a winner call.
Alvarium Tiedemann Holdings Inc. (ALTI) is a asset management company listed on US.
Vertex Pharmaceuticals Inc (VRTX) is a biotechnology company listed on US.
Latest reported ALTI revenue for 2026-06-30 was $131.1M. Net income was -$15.8M. Revenue was up 79.4% from 2026-03-31 to 2026-06-30. ALTI currently screens at market cap $451.8M.
Latest reported VRTX revenue for 2026-06-30 was $3.33B. Net income was $1.10B. Revenue was up 11.6% from 2026-03-31 to 2026-06-30. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
ALTI currently screens at market cap $451.8M. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
Not investment advice. Open the ALTI and VRTX stock pages for the full models.
Not investment advice.